Fisher & Paykel Healthcare Corporation Limited announced that its Director, Donal O'Dwyer's intention to retire as a director of the company with effect from 31 December 2023. The company also announced it has appointed Graham McLean to the Board as a non-executive director with effect from 1 October 2023. An Australian resident, Mr. McLean is currently a director and CEO of CleanSpaceHoldings and chair of Universal Biosensors, two ASX-listed healthcare companies. Graham previously spent 16 years as an executive at leading medical device manufacturer Stryker Corporation, most recently
as President of the Asia Pacific region situated in Hong Kong and Singapore. His tenure with Stryker also included stints as President of Japan and President of the South Pacific region, while his earlier career featured finance, audit and commercial positions at Lion Nathan, McVitie's Ltd. and Unilever. The Fisher & Paykel Healthcare Board has determined that Mr. McLean will be an independent director of the Board. He will also serve as a member of the Audit and Risk Committee, effective 1 October 2023.